Mutations in familial Alzheimer's disease genes, such as
-amyloid precursor protein
(APP)1, presenilin-1, and
presenilin-2, have been shown to regulate the processing of APP and
result in increased production of the longer form of amyloid  peptide (A), A 1-42 (1-5)
